Interferon-gamma production by mononuclear cells in Bacille Calmette-Guérin-revaccinated healthy volunteers predicted long-term antimycobacterial responses in a randomized controlled trial

Vaccine

Volumn 31, Issue 37, 2013, Pages 3778-3782

  Oliveira, Evelin S ^a,b   Marinho, Jamocyr M ^c,d   Barbosa, Theolis ^a,b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^d HOSPITAL SANTA IZABEL   (Brazil)

Author keywords

Correlates of protection; Human populations; Tuberculosis vaccines; Vaccine evaluation

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; MYCOBACTERIUM ANTIGEN;

ADULT; ARTICLE; BCG VACCINATION; CELL EXPANSION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNITY; IN VITRO STUDY; INTERFERON PRODUCTION; LONG TERM CARE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVACCINATION; T LYMPHOCYTE; TUBERCULIN TEST; TUBERCULOSIS;

BACILLE OF CALMETTE-GUÉRIN; BCG; CI; CONFIDENCE INTERVAL; CORRELATES OF PROTECTION; HIV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN POPULATIONS; IFN-Γ; IL; INTERFERON-GAMMA; INTERLEUKIN; M. TUBERCULOSIS H37RV CULTURE LYSATE; MTB; PBMC; PERIPHERAL BLOOD MONONUCLEAR CELLS; PHA; PHYTOHEMAGGLUTININ; PPD; PROTEIN PURIFIED DERIVATIVE; RECEIVER OPERATING CHARACTERISTIC; ROC; TB; TNF; TST; TUBERCULIN SKIN TEST; TUBERCULOSIS; TUBERCULOSIS VACCINES; TUMOR NECROSIS FACTOR.; VACCINE EVALUATION;

BCG VACCINE; HEALTHY VOLUNTEERS; HUMANS; IMMUNITY, CELLULAR; IMMUNIZATION, SECONDARY; INTERFERON-GAMMA; MYCOBACTERIUM BOVIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TUBERCULIN TEST;

EID: 84881548101     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.04.079     Document Type: Article

References (17)

1. Brennan M.J., Thole J. Tuberculosis vaccines: a strategic blueprint for the next decade. Tuberculosis 2012, 92(Suppl. 1):S6-S13.
2. Abebe F. Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology. Clin Exp Immunol 2012, 169:213-219.
3. Hart P.D., Sutherland I. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J 1977, 2:293-295.
4. Weir R.E., Fine P.E.M., Floyd S., Stenson S., Stanley C., Branson K., et al. Comparison of IFN-gamma responses to mycobacterial antigens as markers of response to BCG vaccination. Tuberculosis (Edinb) 2008, 88:31-38.
5. Black G.F., Weir R.E., Floyd S., Bliss L., Warndorff D.K., Crampin A.C., et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 2002, 359:1393-1401.
6. Smith S.G., Lalor M.K., Gorak-Stolinska P., Blitz R., Beveridge N.E.R., Worth A., et al. Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining. BMC Immunol 2010, 11:35.
7. Radošević K., Wieland C.W., Rodriguez A., Weverling G.J., Mintardjo R., Gillissen G., et al. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-Cell epitope mapping and role of gamma interferon. Infect Immun 2007, 75:4105-4115.
8. Barreto M.L., Pereira S.M., Pilger D., Cruz A.A., Cunha S.S., Sant'Anna C., et al. Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial. Vaccine 2011, 29:4875-4877.
9. Barbosa T., Arruda S., Fernandes B.D., Carvalho L.P., Cardoso S., Cunha S., et al. BCG (Bacille of Calmette-Guérin) revaccination leads to improved in vitro IFN-gamma response to mycobacterial antigen independent of tuberculin sensitization in Brazilian school-age children. Vaccine 2003, 21:2152-2160.
10. da Rocha S.S., Marinho J.M., Oliveira E.S., Rodrigues J.S., Conceição E.L., Meira A.E., et al. Non-compliance with health surveillance is a matter of biosafety: a survey of latent tuberculosis infection in a highly endemic setting. BMJ Open 2011, 1:e000079.
11. Duarte T.A., Noronha-Dutra A.A., Nery J.S., Ribeiro S.B., Pitanga T.N., Lapa J.R., et al. Mycobacterium tuberculosis-induced neutrophil ectosomes decrease macrophage activation. Tuberculosis (Edinb) 2012, 92:218-225.
12. Peruhype-Magalhães V., Martins-Filho O.A., Prata A., Silva L.D.A., Rabello A., Teixeira-Carvalho A., et al. Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection. Clin Exp Immunol 2006, 146:124-132.
13. Kagina B.M.N., Abel B., Scriba T.J., Hughes E.J., Keyser A., Soares A., et al. Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns. Am J of Respir Crit Care Med 2010, 182:1073-1079.
14. Diel R., Loddenkemper R., Nienhaus A. Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Chest 2012, 142:63-75.
15. Schulz K.F., Altman D.G., Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c332.
16. Associação Brasileira de Empresas de Pesquisa, Critério de Classificação EconÔmica Brasil, Portal ABEP (2008).
17. World Health Organization Physical status: the use and interpretation of anthropometry 1995, World Health Organization, Geneva, Switzerland.